Xanamem proof-of-concept trial demonstrating anti-depressant activity published in the British Journal of Psychiatry
Ongoing Xanamem (emestedastat) Alzheimer’s disease pivotal trial progresses toward final results in November this year Ongoing Xanamem (emestedastat) Alzheimer’s disease pivotal trial progresses toward final results in November this year
Ongoing Xanamem (emestedastat) Alzheimer’s disease pivotal trial progresses toward final results in November this year Ongoing Xanamem (emestedastat) Alzheimer’s disease pivotal trial progresses toward final results in November this year
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.